Uptake of non-statin lipid-lowering therapies for secondary prevention in community practice
Corey Bradley, Ahmed A. Kolkailah, Nishant Shah, Courtney Page, Eric D. Peterson, Ann Marie Návar
Topics & Concepts
EzetimibeMedicineStatinAtherosclerotic cardiovascular diseaseProprotein convertasePCSK9Internal medicineResidual riskEvolocumabDiseaseLipoproteinCholesterolLDL receptorApolipoprotein A1Lipoproteins and Cardiovascular HealthPharmaceutical Economics and PolicyHealth Systems, Economic Evaluations, Quality of Life